September 2020 – Page 2 – Policy & Medicine

OPDP Sends First Untitled Letter of 2020

House Oversight Committee Subpoenas AbbVie in Drug Pricing Probe

HHS OIG Report Finds Opioid Use Decreasing on Medicare Part D

Drug Pricing Policy Update – Election Uncertainty & Questions about Pricing COVID-19 Remedies

Numerof & Associates Releases Its Fifth Annual Study on Population Health

CMS 2021 Proposed Physician Fee Schedule – Updates to Telehealth, Quality Payment Program and Specialists Reimbursement

Individual NextHealth Marketer Indicted in $60 Million Kickback Scheme

New Research Paper Indicates Price Transparency May Not Equate to Lower Prices

CMS Proposes New Coverage Pathway for Medical Devices

Bausch Health (FKA Valeant Pharmaceuticals) Agrees to $45 Million SEC Settlement